blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1641782

EP1641782 - HYDROXYCARBONYLPHENYL SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES AS 5HT4-ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.09.2011
Database last updated on 04.11.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2010/44]
Former [2006/14]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / BOSMANS, Jean-Paul, René, Marie, André
Janssen Pharmaceutica N.V. Turnhoutseweg 30
B-2340 Beerse / BE
02 / GIJSEN, Henricus, Jacobus, Maria
Janssen Pharmaceutica N.V. Turnhoutseweg 30
B-2340 Beerse / BE
03 / MEVELLEC, Laurence, Anne Janssen-Cilag
1, rue Camille Desmoulins TSA 91003
F-92787 Issy-les-Moulineaux Cedex 9 / FR
 [2006/14]
Representative(s)Michalík, Andrej
De Clercq & Partners cvba E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
[2010/44]
Former [2010/30]Michalík, Andrej
De Clercq & Partners E. Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
Former [2007/22]Brants, Johan P.E.
De Clercq Brants & Partners Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
Former [2006/14]Verberckmoes, Filip Gerard
Janssen Pharmaceutica N.V. Turnhoutseweg 30
B-2340 Beerse / BE
Application number, filing date04739777.310.06.2004
[2006/14]
WO2004EP06274
Priority number, dateWO2003EP5023919.06.2003         Original published format: PCT/EP0350/239
[2006/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005003121
Date:13.01.2005
Language:EN
[2005/02]
Type: A1 Application with search report 
No.:EP1641782
Date:05.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 13.01.2005 takes the place of the publication of the European patent application.
[2006/14]
Type: B1 Patent specification 
No.:EP1641782
Date:03.11.2010
Language:EN
[2010/44]
Search report(s)International search report - published on:EP13.01.2005
ClassificationIPC:C07D405/12, A61P1/00
[2006/14]
CPC:
C07D405/12 (EP,KR,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/06 (EP); A61P1/08 (EP); A61P1/10 (EP);
A61P1/12 (EP); A61P1/14 (EP); A61P13/02 (EP);
A61P13/06 (EP); A61P13/08 (EP); A61P13/10 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P25/14 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P43/00 (EP);
A61P7/12 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/14]
Extension statesAL19.01.2006
HR19.01.2006
LT19.01.2006
LV19.01.2006
MK19.01.2006
TitleGerman:HYDROXYCARBONYLPHENYL SUBSTITUIERTE 4-(AMINOMETHYL)-PIPERIDINBENZAMIDE ALS 5HT4-ANTAGONISTEN[2006/14]
English:HYDROXYCARBONYLPHENYL SUBSTITUTED 4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES AS 5HT4-ANTAGONISTS[2006/14]
French:4-(AMINOMETHYL)-PIPERIDINE BENZAMIDES SUBSTITUES PAR HYDROXYCARBONYLPHENYLE, UTILISES COMME ANTAGONISTES DES RECEPTEURS 5HT4[2006/14]
Entry into regional phase19.01.2006National basic fee paid 
19.01.2006Designation fee(s) paid 
19.01.2006Examination fee paid 
Examination procedure19.01.2006Examination requested  [2006/14]
07.11.2008Despatch of a communication from the examining division (Time limit: M04)
10.03.2009Reply to a communication from the examining division
22.02.2010Communication of intention to grant the patent
16.06.2010Fee for grant paid
16.06.2010Fee for publishing/printing paid
Opposition(s)04.08.2011No opposition filed within time limit [2011/41]
Fees paidRenewal fee
30.06.2006Renewal fee patent year 03
02.07.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
30.06.2009Renewal fee patent year 06
30.06.2010Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
HU03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
TR03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
LU10.06.2011
MC30.06.2011
[2013/45]
Former [2013/44]AT03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
TR03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
LU10.06.2011
MC30.06.2011
Former [2013/26]AT03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
LU10.06.2011
MC30.06.2011
Former [2013/25]AT03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
LU10.06.2011
MC30.06.2011
Former [2013/21]AT03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
MC30.06.2011
Former [2012/20]AT03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
IE10.06.2011
Former [2011/38]AT03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
PL03.11.2010
RO03.11.2010
SE03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
Former [2011/32]AT03.11.2010
FI03.11.2010
SE03.11.2010
SI03.11.2010
BG03.02.2011
GR04.02.2011
PT03.03.2011
Former [2011/24]FI03.11.2010
SE03.11.2010
PT03.03.2011
Cited inInternational search[X]ES2103675  (ALMIRALL LAB [ES]) [X] 1-10* page 2, line 7 - page 2, line 12; examples 2,9 *;
 [DX]WO0037461  (JANSSEN PHARMACEUTICA NV [BE], et al) [DX] 1-10 * page 1, line 5 - page 1, line 8; claim -; compounds 12-15,41-43,77-80-89,127,189 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.